Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Deferred Taxes: 2010-2018

Historic Deferred Taxes for China Pharma Holdings (CPHI) over the last 8 years, with Dec 2018 value amounting to $68,419.

  • China Pharma Holdings' Deferred Taxes fell 103.91% to -$1,195 in Q4 2018 from the same period last year, while for Dec 2018 it was $68,419, marking a year-over-year decrease of 44.21%. This contributed to the annual value of $68,419 for FY2018, which is 44.21% down from last year.
  • As of FY2018, China Pharma Holdings' Deferred Taxes stood at $68,419, which was down 44.21% from $122,631 recorded in FY2017.
  • Over the past 5 years, China Pharma Holdings' Deferred Taxes peaked at $308,175 during FY2016, and registered a low of $68,419 during FY2018.
  • Over the past 3 years, China Pharma Holdings' median Deferred Taxes value was $122,631 (recorded in 2017), while the average stood at $166,408.
  • Data for China Pharma Holdings' Deferred Taxes shows a maximum YoY tumbled of 92.74% (in 2014) over the last 5 years.
  • Yearly analysis of 4 years shows China Pharma Holdings' Deferred Taxes stood at $77,042 in 2014, then reached $308,175 in 2016, then crashed by 60.21% to $122,631 in 2017, then slumped by 44.21% to $68,419 in 2018.